UK markets close in 5 hours 11 minutes
  • FTSE 100

    6,906.99
    +16.50 (+0.24%)
     
  • FTSE 250

    22,300.14
    +31.68 (+0.14%)
     
  • AIM

    1,244.56
    -1.05 (-0.08%)
     
  • GBP/EUR

    1.1519
    +0.0017 (+0.15%)
     
  • GBP/USD

    1.3777
    +0.0025 (+0.18%)
     
  • BTC-GBP

    46,544.40
    +863.21 (+1.89%)
     
  • CMC Crypto 200

    1,381.52
    +87.53 (+6.76%)
     
  • S&P 500

    4,141.59
    +13.60 (+0.33%)
     
  • DOW

    33,677.27
    -68.13 (-0.20%)
     
  • CRUDE OIL

    61.23
    +1.05 (+1.74%)
     
  • GOLD FUTURES

    1,744.20
    -3.40 (-0.19%)
     
  • NIKKEI 225

    29,620.99
    -130.61 (-0.44%)
     
  • HANG SENG

    28,900.83
    +403.58 (+1.42%)
     
  • DAX

    15,228.13
    -6.23 (-0.04%)
     
  • CAC 40

    6,207.96
    +23.86 (+0.39%)
     

Huntington’s Disease - Competitive Landscape in 2021

ReportLinker
·2-min read

Summary "Huntington’s Disease - Competitive Landscape in 2021" combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.

New York, March 12, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Huntington’s Disease - Competitive Landscape in 2021" - https://www.reportlinker.com/p06035017/?utm_source=GNW


Huntington’s disease (HD) protein is a major target of drug developers.There are 138 drugs in the pipeline, 99% 0f which are in early-stage.

Mid-sized Pharma companies dominates R&D in this indication. The addition of improved asymptomatic treatments and potential disease-modifying drugs for HD is expected to drive market growth.

This reports provides a data-driven overview of the current and future competitive landscape in HD therapeutics.

Scope
Components of the report include -
- Disease epidemiology
- Marketed drugs assessment
- Pipeline drugs assessment
- Clinical trials assessment
- Commercial assessment
- Social media overview
- Digital marketing overview

Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global HD market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global HD in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Read the full report: https://www.reportlinker.com/p06035017/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001